{"title": "Clinical Data | PRIORIX (Measles, Mumps, and Rubella Vaccine, Live) for HCPs", "author": null, "url": "https://www.priorix.com/immune-response/clinical-studies/", "hostname": "priorix.com", "description": "Review clinical study data for PRIORIX on the website.", "sitename": "priorix.com", "date": "2022-01-01", "cleaned_text": "INDICATION FOR PRIORIX PRIORIX is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. PRIORIX is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. PRIORIX is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. IMPORTANT SAFETY INFORMATION FOR PRIORIX - Contraindications for PRIORIX are: a history of severe allergic reactions (e.g., anaphylaxis) to - Contraindications for PRIORIX are: a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine or after a previous dose of any measles, mumps, and rubella virus-containing vaccine; severe humoral or cellular (primary or acquired) immunodeficiency; and pregnancy. Pregnancy should be avoided for 1 month after vaccination - Contraindications for PRIORIX are: a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine or after a previous dose of any measles, mumps, and rubella virus-containing vaccine; severe humoral or cellular (primary or acquired) immunodeficiency; and pregnancy. Pregnancy should be avoided for 1 month after vaccination - Appropriate medical treatment used to manage immediate allergic reactions must be available in the event an acute anaphylactic reaction occurs following administration of PRIORIX - There is a risk of febrile seizures following immunization with PRIORIX - Thrombocytopenia and thrombocytopenic purpura have been reported following vaccination with PRIORIX - Syncope (fainting) can occur in association with administration of injectable vaccines, including PRIORIX. Procedures should be in place to avoid injury from fainting - The tip caps of the prefilled syringes of diluent contain natural rubber latex, which may cause allergic reactions - Vaccination with PRIORIX may not result in protection in all vaccine recipients - In clinical trials, the most commonly reported (10%) solicited adverse reactions were: - Administration of immune globulins and other blood products concurrently with PRIORIX may interfere with the expected immune response to the vaccine - If a tuberculin test is to be done, it should be administered either any time before, simultaneously with, or at least 4 weeks after PRIORIX to avoid false-negative results - Age 12 through 15 months-local: pain (26%) and redness drowsiness (35%) - Age 4 through years-local: pain (41%), redness (22%) and swelling (11%); appetite (21%), drowsiness (27%), and fever (24%) - Age 7 years and older-local: pain (12%) and redness (12%) "}